For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment. The Scottish Medicines Consortium has accepted the chemotherapy-free treatment of Venclyxto (venetoclax) and Obinutuzumab for Scottish patients living with Chronic Lymphocytic Leukaemia (CCL), the most common form of adult leukaemia in the UK. The treatment [ ]
The post Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients appeared first on Health Europa.
Thursday 28 January 2021
healtheuropa - 2 month ago
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients
Latest News
⁞
Sources